Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Speth

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Frontiers in Cell and Developmental Biology|June 9, 2023
Hippocampal versus cortical deletion of cholinergic receptor muscarinic 1 in mice differentially affects post-translational modifications and supramolecular assembly of respiratory chain-associated proteins, mitochondrial ultrastructure, and respiration: implications in Alzheimer's diseaseMohammad Golam Sabbir, Mamiko Swanson, Robert C Speth, et al.
Experimental Brain Research|January 25, 2002
Angiotensin II receptor subtype distribution in the rabbit brainSabyasachi Moulik, Robert C Speth, Barbara B Turner, et al.
Journal of Visualized Experiments : Jove|June 25, 2016
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II ReceptorsAndrea Linares, Leena E Couling, Eduardo J Carrera, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 2009
Brain AT1 angiotensin receptor subtype binding: importance of peptidase inhibition for identification of angiotensin II as its endogenous ligandVardan T Karamyan, Rama Gadepalli, John M Rimoldi, et al.
Trends in Molecular Medicine|October 22, 2024
Assessment of the therapeutic potential of salubrinal for ME/CFS and long-COVIDAseel Warrayat, Ayah Ali, Joulin Waked, et al.
Regulatory Peptides|March 21, 2013
The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysinKira L Santos, Megan A Vento, John W Wright, et al.
Neurochemical Research|July 4, 2015
Selective C1 Lesioning Slightly Decreases Angiotensin II Type I Receptor Expression in the Rat Rostral Ventrolateral Medulla (RVLM)Erick A Bourassa, Kristen A Stedenfeld, Alan F Sved, et al.
Proceedings of the Western Pharmacology Society|January 1, 2004
Brain angiotensinergic activity: the state of our current knowledgeRobert C Speth, Travis E Brown, Ryan D Barnes, et al.
International Journal of Hypertension|April 11, 2013
Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective CommentaryCourtney Premer, Courtney Lamondin, Ann Mitzey, et al.
European Journal of Pharmacology|June 24, 2008
Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouseVardan T Karamyan, Florian Gembardt, Felicia M Rabey, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Cell and Developmental Biology|June 9, 2023
Hippocampal versus cortical deletion of cholinergic receptor muscarinic 1 in mice differentially affects post-translational modifications and supramolecular assembly of respiratory chain-associated proteins, mitochondrial ultrastructure, and respiration: implications in Alzheimer's diseaseMohammad Golam Sabbir, Mamiko Swanson, Robert C Speth, et al.
Experimental Brain Research|January 25, 2002
Angiotensin II receptor subtype distribution in the rabbit brainSabyasachi Moulik, Robert C Speth, Barbara B Turner, et al.
Journal of Visualized Experiments : Jove|June 25, 2016
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II ReceptorsAndrea Linares, Leena E Couling, Eduardo J Carrera, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 2009
Brain AT1 angiotensin receptor subtype binding: importance of peptidase inhibition for identification of angiotensin II as its endogenous ligandVardan T Karamyan, Rama Gadepalli, John M Rimoldi, et al.
Trends in Molecular Medicine|October 22, 2024
Assessment of the therapeutic potential of salubrinal for ME/CFS and long-COVIDAseel Warrayat, Ayah Ali, Joulin Waked, et al.
Regulatory Peptides|March 21, 2013
The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysinKira L Santos, Megan A Vento, John W Wright, et al.
Neurochemical Research|July 4, 2015
Selective C1 Lesioning Slightly Decreases Angiotensin II Type I Receptor Expression in the Rat Rostral Ventrolateral Medulla (RVLM)Erick A Bourassa, Kristen A Stedenfeld, Alan F Sved, et al.
Proceedings of the Western Pharmacology Society|January 1, 2004
Brain angiotensinergic activity: the state of our current knowledgeRobert C Speth, Travis E Brown, Ryan D Barnes, et al.
International Journal of Hypertension|April 11, 2013
Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective CommentaryCourtney Premer, Courtney Lamondin, Ann Mitzey, et al.
European Journal of Pharmacology|June 24, 2008
Characterization of the brain-specific non-AT(1), non-AT(2) angiotensin binding site in the mouseVardan T Karamyan, Florian Gembardt, Felicia M Rabey, et al.
Pageof 12